BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21980916)

  • 1. A reduced-amide inhibitor of Pin1 binds in a conformation resembling a twisted-amide transition state.
    Xu GG; Zhang Y; Mercedes-Camacho AY; Etzkorn FA
    Biochemistry; 2011 Nov; 50(44):9545-50. PubMed ID: 21980916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
    Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
    J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclohexyl ketone inhibitors of Pin1 dock in a trans-diaxial cyclohexane conformation.
    Xu GG; Slebodnick C; Etzkorn FA
    PLoS One; 2012; 7(9):e44226. PubMed ID: 23028504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
    Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
    Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-based design of reversible Pin1 inhibitors.
    Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
    Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergent synthesis of alpha-ketoamide inhibitors of Pin1.
    Xu GG; Etzkorn FA
    Org Lett; 2010 Feb; 12(4):696-9. PubMed ID: 20102178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptidyl-prolyl isomerase inhibitors.
    Wang XJ; Etzkorn FA
    Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereospecific gating of functional motions in Pin1.
    Namanja AT; Wang XJ; Xu B; Mercedes-Camacho AY; Wilson KA; Etzkorn FA; Peng JW
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12289-94. PubMed ID: 21746900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of novel human Pin1 inhibitors (I).
    Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.
    Duncan KE; Dempsey BR; Killip LE; Adams J; Bailey ML; Lajoie GA; Litchfield DW; Brandl CJ; Shaw GS; Shilton BH
    J Med Chem; 2011 Jun; 54(11):3854-65. PubMed ID: 21545152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane permeable cyclic peptidyl inhibitors against human Peptidylprolyl Isomerase Pin1.
    Liu T; Liu Y; Kao HY; Pei D
    J Med Chem; 2010 Mar; 53(6):2494-501. PubMed ID: 20180533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
    Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
    Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic insights into Pin1 peptidyl-prolyl cis-trans isomerization from umbrella sampling simulations.
    Di Martino GP; Masetti M; Cavalli A; Recanatini M
    Proteins; 2014 Nov; 82(11):2943-56. PubMed ID: 25066180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for high-affinity peptide inhibition of human Pin1.
    Zhang Y; Daum S; Wildemann D; Zhou XZ; Verdecia MA; Bowman ME; Lücke C; Hunter T; Lu KP; Fischer G; Noel JP
    ACS Chem Biol; 2007 May; 2(5):320-8. PubMed ID: 17518432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phosphorylated prodrug for the inhibition of Pin1.
    Zhao S; Etzkorn FA
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6615-8. PubMed ID: 17935986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereochemical Control in the Still-Wittig Rearrangement Synthesis of Cyclohexyl (Z)-Alkene Inhibitors of Pin1.
    Chen XR; Fan SA; Ware RI; Etzkorn FA
    PLoS One; 2015; 10(10):e0139543. PubMed ID: 26445009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked enzyme-binding assay for Pin1 WW domain ligands.
    Mercedes-Camacho AY; Etzkorn FA
    Anal Biochem; 2010 Jul; 402(1):77-82. PubMed ID: 20230769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of novel human Pin1 inhibitors (II).
    Dong L; Marakovits J; Hou X; Guo C; Greasley S; Dagostino E; Ferre R; Johnson MC; Kraynov E; Thomson J; Pathak V; Murray BW
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2210-4. PubMed ID: 20207139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
    Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
    Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.